Emeren Group Ltd ("Emeren" or the "Company") ( (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced the completion of the merger contemplated by the previously ...
SpaceX's public offering strategy will raise more than $30 billion—three times more than the company has raised in its entire ...
FDA confirmed that data from single-arm studies in rare diseases, such as in ultra-rare deadly pediatric cancer osteosarcoma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results